• Treatments and Therapies

  PAH Therapy Livantra Gets FDA Orphan Drug Status

  Posted by Pulmonary Hypertension News Moderator on August 20, 2018 at 9:42 am

  The FDA granted orphan status to Livantra, a repurposed drug approved for another indication outside the U.S., for the treatment of PAH.

  Read more about this possible treatment option for PH here.

  What are your thoughts on this news?

  Pulmonary Hypertension News Moderator replied 5 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply